The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study-Reference-Cited by-同舟云学术

The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study

Published:2016-05-21 Issue:1 Volume:26 Page:35-46
ISSN:1018-8827
Container-title:European Child & Adolescent Psychiatry
language:en
Short-container-title:Eur Child Adolesc Psychiatry

Author:

Baeza Inmaculada,Vigo Laura,de la Serna Elena,Calvo-Escalona Rosa,Merchán-Naranjo Jessica,Rodríguez-Latorre Pamela,Arango Celso,Castro-Fornieles Josefina

Funder

Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Ministry of Health, Spain

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Developmental and Educational Psychology,General Medicine,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00787-016-0866-x.pdf

Reference60 articles.

1. Baeza I, De la Serna E, Calvo-Escalona R, Morer A, Merchán-Naranjo J, Tapia C, Martínez-Cantarero MC, Andrés P, Alda JA, Sánchez B, Arango C, Castro-Fornieles J (2014) Antipsychotic use in children and adolescents. A 1-year follow-up study. J Clin Psychopharmacol 5:613–619

2. Olfson M, Blanco C, Liu SM, Wang S, Correll CU (2012) National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry 69:1247–1256

3. Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C (2011) Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol 21:621–645

4. Arango C (2015) Present and future of developmental neuropsychopharmacology. Eur Neuropsychopharmacol 25:703–712

5. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK (2009) Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 302:1765–1773

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways;International Immunopharmacology;2024-10

2. Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis;Psychiatry Research;2024-04

3. Association of homocysteine with white matter dysconnectivity in schizophrenia;Schizophrenia;2024-03-20

4. Implementation of a lifestyle and life‐skills intervention to prevent weight‐gain and cardiometabolic abnormalities in young people with first‐episode psychosis as part of routine care: The Keeping the Body in Mind program;Early Intervention in Psychiatry;2024-02-09

5. 14. Children and Adolescents: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11